Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Silverman

Showing results (391-400 of 593) with videos related to

Pageof 60
Sort By:
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repressionJ C Achermann, M Ito, B L Silverman, et al.
Optics Express|February 3, 2016
Monolithic device for modelocking and stabilization of frequency combsC-C Lee, Y Hayashi, K L Silverman, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|December 16, 2014
Simulation of Tangential Excision: A Test for Construct ValidityJames J Gallagher, Ian M Goldin, Geoffrey M O'Sullivan, et al.
Pain Medicine (Malden, Mass.)|January 10, 2014
Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impactStephen S Johnston, Margarita Udall, Joseph C Cappelleri, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 7, 2012
[Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomized trial]E M Krupitskiĭ, E V Nunes, W Ling, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 17, 2015
[Injectable extended-release naltrexone for opioid dependence: an open label study of long-term safety and efficacy]E M Krupitsky, E V Nunes, W Ling, et al.
Pain Medicine (Malden, Mass.)|May 20, 2017
Effect of Baseline Characteristics on the Pain Response to Pregabalin in Fibromyalgia Patients with Comorbid DepressionStuart L Silverman, Miroslav Backonja, Lynne Pauer, et al.
American Journal of Medical Genetics. Part A|April 5, 2023
Quantitative measures of motor development in Angelman syndromeJessica Duis, Austin Skinner, Robert Carson, et al.
The Journal of Urology|October 5, 2001
Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesionsJ M Latini, K M Rieger-Christ, D S Wang, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 4, 2013
Cost comparison of drug-drug and drug-condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetineStephen S Johnston, Margarita Udall, Joseph C Cappelleri, et al.
Pageof 60

Showing results (391-400 of 593) with videos related to

Sort By:
Pageof 60
The Journal of Clinical Endocrinology and Metabolism|July 10, 2001
Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repressionJ C Achermann, M Ito, B L Silverman, et al.
Optics Express|February 3, 2016
Monolithic device for modelocking and stabilization of frequency combsC-C Lee, Y Hayashi, K L Silverman, et al.
Journal of Burn Care & Research : Official Publication of the American Burn Association|December 16, 2014
Simulation of Tangential Excision: A Test for Construct ValidityJames J Gallagher, Ian M Goldin, Geoffrey M O'Sullivan, et al.
Pain Medicine (Malden, Mass.)|January 10, 2014
Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impactStephen S Johnston, Margarita Udall, Joseph C Cappelleri, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 7, 2012
[Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomized trial]E M Krupitskiĭ, E V Nunes, W Ling, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 17, 2015
[Injectable extended-release naltrexone for opioid dependence: an open label study of long-term safety and efficacy]E M Krupitsky, E V Nunes, W Ling, et al.
Pain Medicine (Malden, Mass.)|May 20, 2017
Effect of Baseline Characteristics on the Pain Response to Pregabalin in Fibromyalgia Patients with Comorbid DepressionStuart L Silverman, Miroslav Backonja, Lynne Pauer, et al.
American Journal of Medical Genetics. Part A|April 5, 2023
Quantitative measures of motor development in Angelman syndromeJessica Duis, Austin Skinner, Robert Carson, et al.
The Journal of Urology|October 5, 2001
Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesionsJ M Latini, K M Rieger-Christ, D S Wang, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 4, 2013
Cost comparison of drug-drug and drug-condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetineStephen S Johnston, Margarita Udall, Joseph C Cappelleri, et al.
Pageof 60